MedPath
Found 1 clinical trials|View Analysis
Sort by:

Study of ONO-7914 Alone and in Combination With ONO-4538 in Patients With Solid Tumors

Phase 1
Recruiting
Conditions
Solid Tumor
Interventions
Drug: ONO-7914
Drug: ONO-4538
First Posted Date
2024-08-02
Last Posted Date
2024-08-02
Lead Sponsor
Ono Pharmaceutical Co. Ltd
Target Recruit Count
204
Registration Number
NCT06535009
Locations
🇯🇵

Cancer Institute Hospital of JFCR, Koto-ku, Tokyo, Japan

© Copyright 2025. All Rights Reserved by MedPath